FIREFLY NEUROSCIENCE, INC. 8-K

What Happened Firefly Neuroscience, Inc. (AIFF) announced via Form 8-K filed June 26, 2026 (Item 1.02) that it and an accredited investor mutually agreed in writing to terminate a securities purchase agreement dated May 6, 2026. Under the original Purchase Agreement (disclosed May 12, 2026), the company had agreed to issue and sell up to 666,667 units at $1.50 per unit for aggregate gross proceeds of up to $1,000,000. The termination was effective June 25, 2026 pursuant to Section 5.3 of the agreement.

Key Details

• Purchase Agreement date: May 6, 2026 (previously disclosed May 12, 2026).
• Offered securities: up to 666,667 units at $1.50 per unit.
• Maximum gross proceeds that will not be received under this agreement: $1,000,000.
• Termination: mutual written agreement, effective June 25, 2026 (reported in 8-K filed June 26, 2026).

Why It Matters The terminated agreement means Firefly will not receive the up-to-$1.0M of financing contemplated by that Purchase Agreement. For investors, this is a concrete change to the company’s near-term financing expectations — it reduces a previously disclosed potential source of capital. The filing provides no additional details about replacement financing or the reasons for termination, so shareholders should watch future filings or company communications for updates on liquidity or alternative capital raises.